NASDAQ:IFRX

Inflarx N.v Stock Predictions

etoro logo Buy IFRX
*Your capital is at risk
$2.06
-0.110 (-5.07%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IFRX Prediction Chart

IFRX Predictions History

Latest community submissions for IFRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 20, 2026 $1.04 +3.52% $0.99 X 95.33% 0
Jan 20, 2026 $1.02 +2.20% $0.99 X 96.66% 0
Jan 20, 2026 Bullish $0.99 X 0
Nov 14, 2025 $1.36 +6.79% $1.35 V 99.53% 5
Nov 14, 2025 $1.32 +4.25% $1.35 V 98.07% 1
Nov 14, 2025 Bullish $1.35 X 1
Oct 6, 2025 $1.52 -3.62% $1.51 V 99.15% 3
Oct 6, 2025 $1.54 -2.26% $1.51 V 97.73% 1
Oct 6, 2025 Bullish $1.51 V 0
Sep 16, 2025 $1.29 +5.25% $1.14 X 86.44% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IFRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT INFLARX N.V.
InflaRx N.V
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE